Ancora Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Ancora Advisors’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-18	Closed	–	–	2367
2022 Q2	$0	Hold	18	–	–	﹤0.01%	2524
2022 Q1	$0	Hold	18	–	–	﹤0.01%	2702
2021 Q4	$0	Hold	18	–	–	﹤0.01%	2503
2021 Q3	$0	Hold	18	–	–	﹤0.01%	2330
2021 Q2	$0	Hold	18	–	–	﹤0.01%	2069
2021 Q1	$0	Hold	18	–	–	﹤0.01%	1860
2020 Q4	$0	Hold	18	–	–	﹤0.01%	1558
2020 Q3	$0	Hold	18	–	–	﹤0.01%	1475
2020 Q2	$0	Hold	18	–	–	﹤0.01%	1476
2020 Q1	$0	Hold	18	–	–	﹤0.01%	1523
2019 Q4	$0	Buy	+18	New	+$52	﹤0.01%	1380
2016 Q2	–	Sell	-1,948	Closed	-$28K	–	544
2016 Q1	$28K	Hold	1,948	–	–	﹤0.01%	493
2015 Q4	$34K	Buy	1,948 +812	+71%	+$13.7K	﹤0.01%	494
2015 Q3	$17K	Buy	+1,136	New	+$21.6K	﹤0.01%	492

Other funds holding APEN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Ancora Advisors's APEN Position: Q3 2022 in Review

Ancora Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 18 shares.

Ancora Advisors first reported a position in APEN in Q3 2015 and held it in 14 quarters. The position peaked at $34K in Q4 2015. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

Ancora Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
Ancora Advisors sold 18 Apollo Endosurgery, Inc. shares in Q3 2022.
Ancora Advisors first reported a position in Apollo Endosurgery, Inc. in Q3 2015 and held it in 14 quarters.
Ancora Advisors's Apollo Endosurgery, Inc. position peaked at $34K in Q4 2015.
53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.